Azzam Bilal Chamdy
Neng Nana
Nana Muazin
Dwi Wanna
Raul Delapena Setiawan
COPENHAGEN, Denmark – In a significant move to reinforce the pillars of global health security and institutional synergy, the World Health Organization (WHO) and the Swiss Confederation have officially renewed their Cooperation Strategy for the 2024–2028 period. The agreement, signed on March 4, 2025, at the WHO Regional Office for Europe in Copenhagen, signals a deepened commitment to addressing the complex, evolving health challenges of the 21st century.
This strategic framework serves as a roadmap for the partnership between one of the world’s most influential health bodies and a nation that serves as a cornerstone of international health diplomacy and innovation.
The Core Pillars of the New Strategic Framework
The 2024–2028 Cooperation Strategy is not merely a bureaucratic continuation of past efforts; it is a refined instrument designed to respond to the lessons learned from the COVID-19 pandemic and the increasing burden of non-communicable diseases. The strategy focuses on four primary objectives:
- Enhancing Global Health Security: Building resilient health systems capable of detecting and mitigating future pandemic threats.
- Digital Health and Data Governance: Leveraging Switzerland’s technological prowess to improve data-sharing protocols and digital health equity across the European region.
- Sustainable Health Financing: Promoting long-term, predictable funding mechanisms that allow for proactive, rather than reactive, health initiatives.
- Health Diplomacy and Governance: Strengthening the multilateral system to ensure that health remains a priority in the global geopolitical agenda.
By formalizing these objectives, both parties aim to transition from collaborative projects to a more integrated, systemic approach to health governance.
A Chronology of Partnership: From Pilot to Pillar
The relationship between the WHO and Switzerland is unique, defined by deep historical roots and a shared vision for universal health coverage.
2013: The Genesis of the Cooperation Model
In 2013, Switzerland made history by becoming the first high-income country in the WHO European Region to pilot a formal Country Cooperation Strategy (CCS). At the time, the concept of a CCS was typically reserved for low- and middle-income nations requiring technical assistance. Switzerland’s decision to adopt this model signaled a paradigm shift: it acknowledged that even highly developed, wealthy nations benefit from the structural oversight and normative guidance provided by the WHO.
2022: The Strategic Pivot
Following the global upheaval caused by the COVID-19 pandemic, both the WHO and Swiss officials recognized that the 2013 framework was no longer sufficient to address the realities of the post-pandemic era. In 2022, a joint decision was reached to initiate a comprehensive review and update of the existing strategy. This was an arduous, multi-year process involving stakeholders from the Swiss Federal Office of Public Health (FOPH) and WHO technical departments.
2025: Formalization and Future-Proofing
The March 4, 2025, signing ceremony represented the culmination of these efforts. Dr. Hans Kluge, WHO Regional Director for Europe, and Barbara Schedler, Ambassador for Global Health at the Swiss Federal Office of Public Health, met in Copenhagen to finalize the document, cementing a collaborative trajectory that extends through the end of 2028.
Supporting Data: Why This Partnership Matters
The importance of this cooperation is best understood through the lens of Switzerland’s unique position in the global health ecosystem. Switzerland is not only a host nation to the WHO headquarters in Geneva but also a critical hub for pharmaceutical innovation, biomedical research, and global health policy.
- The Global BioHub System: One of the most tangible outcomes of this partnership is the WHO BioHub System, established to facilitate the rapid sharing of pathogens with pandemic potential. This system allows for the swift development of diagnostics, therapeutics, and vaccines. Switzerland’s commitment to providing the infrastructure for this initiative is vital to global surveillance.
- Regional Influence: The WHO European Region, encompassing 53 member states, faces unique challenges, including aging populations and the integration of migrant health services. Switzerland’s role as a model for universal health coverage provides a blueprint for other nations in the region that are currently navigating fiscal constraints and demographic shifts.
Official Responses and Diplomatic Perspectives
The signing ceremony highlighted the mutual appreciation between the two entities.
"This agreement is a testament to the fact that health is not a local concern, but a global public good," stated Dr. Hans Kluge during the press briefing. "Switzerland has consistently proven itself to be a forward-thinking partner. By aligning our national priorities with WHO’s regional and global objectives, we are creating a force multiplier for health equity."
Ambassador Barbara Schedler emphasized the responsibility that comes with Switzerland’s status in the health sector. "For Switzerland, this strategy is about more than policy; it is about accountability. As we navigate a world of geopolitical fragmentation, our partnership with the WHO ensures that science and humanitarian values remain the bedrock of our foreign health policy."
The WHO Media Team noted that this collaboration is expected to serve as a template for other high-income nations looking to maximize their contribution to international health standards.
Implications for Global Health Policy (2024–2028)
The renewal of this strategy carries significant implications for the next four years of global health governance.
Strengthening Multilateralism
In an era where international organizations are frequently under political pressure, the robust, transparent cooperation between Switzerland and the WHO reinforces the relevance of multilateral institutions. It provides a stable anchor for the WHO as it seeks to reform its own administrative and operational structures.
Focus on Innovation and Equity
The strategy emphasizes that technological advancements—such as AI in diagnostic imaging or genomic surveillance—must not widen the gap between wealthy and impoverished nations. By working together, Switzerland and the WHO intend to promote "equitable innovation," ensuring that health technologies are developed with global distribution in mind.
Crisis Preparedness and Response
The COVID-19 pandemic exposed systemic weaknesses in international coordination. The 2024–2028 strategy specifically addresses the "last mile" of pandemic preparedness: the ability to manufacture and distribute countermeasures locally. Through the BioHub system and related initiatives, this partnership is designed to ensure that the global health community is never again caught as unprepared as it was in early 2020.
Conclusion: A Blueprint for the Future
The WHO-Switzerland Cooperation Strategy 2024–2028 is a landmark document that reflects the maturity of a long-standing partnership. By evolving from a simple advisory relationship into a strategic, operational alliance, both parties have set a standard for how high-income nations can effectively engage with international health bodies.
As the world faces an era of climate change-induced health risks, antibiotic resistance, and the constant specter of zoonotic diseases, the stability offered by this cooperation will be indispensable. The coming four years will be critical in testing the efficacy of this framework, but the foundation laid in Copenhagen provides a clear path forward: one of shared data, shared responsibility, and a shared commitment to the fundamental right to health for all people.
For those interested in the granular details of the roadmap, the full text of the WHO-Switzerland Country Cooperation Strategy 2024–2028 is available through the official WHO/Europe portal. This document is expected to influence not only the bilateral relationship between these two entities but also the strategic planning of other member states within the European region and beyond.
For further inquiries regarding the implementation of this strategy, please contact the WHO Media Team or the Swiss Federal Office of Public Health.
Lina Irawan
